{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T01:24:39Z","timestamp":1791163479118,"version":"4.1.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,9,11]],"date-time":"2013-09-11T00:00:00Z","timestamp":1378857600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-2261-13-71","type":"journal-article","created":{"date-parts":[[2013,9,11]],"date-time":"2013-09-11T12:55:37Z","timestamp":1378904137000},"source":"Crossref","is-referenced-by-count":6,"title":["There are considerable drawbacks to oral anticoagulant for monitoring patients at home which should lead family physicians to discuss alternative or enhanced solutions: a cross-sectional study"],"prefix":"10.1186","volume":"13","author":[{"given":"Jean Yves","family":"Le Reste","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Chiron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Le Floch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Nabbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Barrais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Mansourati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Cadier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Barraine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Lietard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,9,11]]},"reference":[{"key":"606_CR1","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1001\/archinte.167.13.1414","volume":"167","author":"DK Wysowski","year":"2007","unstructured":"Wysowski DK, Nourjah P, Swartz L: Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action. Arch Intern Med. 2007, 167: 1414-1419. 10.1001\/archinte.167.13.1414.","journal-title":"Arch Intern Med"},{"key":"606_CR2","volume-title":"Drees - Minist\u00e8re des Affaires sociales et de la Sant\u00e9","author":"P Michel","year":"2005","unstructured":"Michel P, Quenon JL, Djihoud A, Tricaud-Vialle S, De Saraquesta AM: Les \u00e9v\u00e9nements ind\u00e9sirables graves li\u00e9s aux soins observ\u00e9s dans les \u00e9tablissements de sant\u00e9. Drees - Minist\u00e8re des Affaires sociales et de la Sant\u00e9. 2005, Available from: \n                    http:\/\/www.drees.sante.gouv.fr\/les-evenements-indesirables-graves-lies-aux-soins-observes-dans-les-etablissements-de-sante-premiers-resultats-d-une-etude-nationale\n                    \n                  ,4542.html. [cited 2012 Oct 30]"},{"key":"606_CR3","unstructured":"Castot A, Haramburu F, Kreft-Ja\u00efs C: Evaluation du risque de iatrogenie medicamenteuse. Minist\u00e8re des Affaires sociales et de la Sant\u00e9, Available from: \n                    http:\/\/www.sante.gouv.fr\/evaluation-du-risque-d-iatrogenie-medicamenteuse.html\n                    \n                  . [cited 2012 Oct 30]"},{"key":"606_CR4","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.cca.2009.09.014","volume":"410","author":"B Goswami","year":"2009","unstructured":"Goswami B, Tayal D, Chawla R, Mallika V: Pre-analytical factors that influence the interpretation of prothrombin time in the clinical laboratory: one year experience in a super speciality hospital in India. Clin Chim Acta. 2009, 410: 93-94. 10.1016\/j.cca.2009.09.014.","journal-title":"Clin Chim Acta"},{"key":"606_CR5","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1055\/s-2003-44460","volume":"3","author":"A Tripodi","year":"2003","unstructured":"Tripodi A, Breukink-Engbers WGM, van den Besselaar AMHP: Oral anticoagulant monitoring by laboratory or near-patient testing: what a clinician should be aware of. Semin Vasc Med. 2003, 3: 243-254.","journal-title":"Semin Vasc Med"},{"key":"606_CR6","unstructured":"Chastagner M, Gault M, Lefevre Schmitt N, Chabrerie S, Van Keirsbilck C: Le bon usage des Antivitamines K. Programme R\u00e9gional de l\u2019Assurance Maladie 2002\u20132003 urcam limousin. Available from: \n                    http:\/\/ars.sante.fr\/fileadmin\/LIMOUSIN\/publications\/avk_synthese_08aout2003.pdf\n                    \n                  . [cited 2012 Oct 30]"},{"key":"606_CR7","unstructured":"Lucas-barbre C: Surveillance biologique du traitement par antivitamines-K: enqu\u00eate sur la coordination des soins entre les professionnels de sant\u00e9 concern\u00e9s, dans le Finist\u00e8re Nord. Service universitaire de documentation 2006. Available from: \n                    http:\/\/www.sudoc.fr\/10802248X\n                    \n                  . [cited 2012 Oct 30]"},{"key":"606_CR8","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1080\/10245330400010646","volume":"9","author":"MA Awad","year":"2004","unstructured":"Awad MA, Selim TE, Al-Sabbagh FA: Influence of storage time and temperature on international normalized ratio (INR) levels and plasma activities of vitamin K dependent clotting factors. Hematology. 2004, 9: 333-337. 10.1080\/10245330400010646.","journal-title":"Hematology"},{"key":"606_CR9","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1373\/clinchem.2004.043174","volume":"51","author":"JHH van Geest-Daalderop","year":"2005","unstructured":"van Geest-Daalderop JHH, Mulder AB, Boonman-de Winter LJM, Hoekstra MMCL, van den Besselaar AMHP: Preanalytical variables and off-site blood collection: influences on the results of the prothrombin time\/international normalized ratio test and implications for monitoring of oral anticoagulant therapy. Clin Chem. 2005, 51: 561-568. 10.1373\/clinchem.2004.043174.","journal-title":"Clin Chem"},{"issue":"9813","key":"606_CR10","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/S0140-6736(11)61294-4","volume":"379","author":"C Heneghan","year":"2012","unstructured":"Heneghan C, Ward A, Perera R, Bankhead C, Fuller A, Stevens R: Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data. Lancet. 2012, 379 (9813): 322-334. 10.1016\/S0140-6736(11)61294-4.","journal-title":"Lancet"},{"key":"606_CR11","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1056\/NEJMoa1002617","volume":"363","author":"DB Matchar","year":"2010","unstructured":"Matchar DB, Jacobson A, Dolor R, Edson R, Uyeda L, Phibbs CS: Effect of home testing of international normalized ratio on clinical events. New Engl J Med. 2010, 363: 1608-1620. 10.1056\/NEJMoa1002617.","journal-title":"New Engl J Med"},{"key":"606_CR12","volume-title":"Traitement par antivitamines K. HAS","author":"Haute Autorit\u00e9 de Sant\u00e9","year":"2012","unstructured":"Haute Autorit\u00e9 de Sant\u00e9: Traitement par antivitamines K. HAS. 2012, Available from: \n                    http:\/\/www.has-sante.fr\/portail\/jcms\/c_1168574\/traitement-par-antivitamines-k\n                    \n                  . [cited 2012 Oct 30]"},{"issue":"6","key":"606_CR13","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/00001721-200009000-00008","volume":"11","author":"AM van den Besselaar","year":"2000","unstructured":"van den Besselaar AM, Meeuwisse-Braun J, Schaefer-van Mansfeld H, van Rijn C, Witteveen E: A comparison between capillary and venous blood international normalized ratio determinations in a portable prothrombin time device. Blood Coagul Fibrinolysis. 2000, 11 (6): 559-562. 10.1097\/00001721-200009000-00008.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"606_CR14","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1016\/j.jacc.2010.09.017","volume":"56","author":"SH Schirmer","year":"2010","unstructured":"Schirmer SH, Baumh\u00e4kel M, Neuberger H-R, Hohnloser SH, van Gelder IC, Lip GY, B\u00f6hm M: Novel anticoagulants for stroke prevention in atrial fibrillation: current clinical evidence and future developments. J Am Coll Cardiol. 2010, 56: 2067-2076. 10.1016\/j.jacc.2010.09.017.","journal-title":"J Am Coll Cardiol"},{"key":"606_CR15","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/1471-2296-7-67","volume":"7","author":"S Andersson","year":"2006","unstructured":"Andersson S, Bj\u00f6rholt I, Nilsson GH, Krakau I: Resource consumption and management associated with monitoring of warfarin treatment in primary health care in Sweden. BMC family practice. 2006, 7: 67-10.1186\/1471-2296-7-67.","journal-title":"BMC family practice"},{"key":"606_CR16","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s00115-010-3114-5","volume":"82","author":"R Veltkamp","year":"2011","unstructured":"Veltkamp R, Hacke W: New oral anticoagulants in atrial fibrillation. Nervenarzt. 2011, 82: 180-189. 10.1007\/s00115-010-3114-5.","journal-title":"Nervenarzt"},{"key":"606_CR17","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.pharmthera.2010.12.007","volume":"130","author":"T Mavrakanas","year":"2011","unstructured":"Mavrakanas T, Bounameaux H: The potential role of new oral anticoagulants in the prevention and treatment of thromboembolism. Pharmacol Ther. 2011, 130: 46-58. 10.1016\/j.pharmthera.2010.12.007.","journal-title":"Pharmacol Ther"},{"key":"606_CR18","unstructured":"Saint Germes M: Enqu\u00eate sur la coordination des principaux professionnels de sant\u00e9 (m\u00e9decin traitant, infirmi\u00e8re lib\u00e9rale, biologiste) dans la surveillance biologique des patients sous antivitamine K en r\u00e9gion Midi-Pyr\u00e9n\u00e9es. Service universitaire de documentation; 2008. Available from: \n                    http:\/\/www.sudoc.fr\/136252893\n                    \n                   [cited 2012 Oct 30]"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2261-13-71.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2261-13-71\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2261-13-71","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2261-13-71.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T20:39:25Z","timestamp":1548189565000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/1471-2261-13-71"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,11]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["606"],"URL":"https:\/\/doi.org\/10.1186\/1471-2261-13-71","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,11]]},"article-number":"71"}}